Sonoran Biosciences
  • Company
    • About Us
    • Team
  • SB Gel
  • SBG004 – Pain
  • SBG003 – SSI
  • News
  • Contact
  • Search
  • Menu

News

January 2, 2025

Sonoran Biosciences has received a Phase 2 SBIR award from the National Institutes of Health for $2.49 million

Read more

September 24, 2024

Sonoran Biosciences Announces Issuance of a Second US Patent for Its SB Gel Extended-Release Technology

Read more

July 3, 2024

Sonoran Biosciences Reports Publication of Positive Results in a Knee Surgery Model of Postoperative Pain

Read more

September 6, 2022

Sonoran Biosciences has received a Phase 1 SBIR award from the National Institutes of Health for $259,613

Read more

August 9, 2022

Sonoran Biosciences Reports Publication of Analgesia Results for Postoperative Pain Program

Read more

November 16, 2021

Sonoran Biosciences Announces Issuance of US Patent For SB Gel Extended-Release Technology

Read more

June 15, 2021

Sonoran Biosciences Reports Positive Results for Postoperative Pain Program

Read more

August 3, 2020

Sonoran Biosciences Announces Qualified Infectious Disease Product (QIDP) Designation Granted by FDA for SBG003 for Surgical Site Infections in Abdominal Surgery

Read more

August 1, 2019

Sonoran Biosciences has received a Phase 2B SBIR award from the National Institutes of Health for $2 million

Read more

October 24, 2018

Sonoran Biosciences has filed a new patent application on the SB Gel platform

Read more

October 11, 2018

Sonoran Biosciences announces new Board of Directors

Read more

January 12, 2018

Sonoran Biosciences welcomes three new Clinical Advisors

Read more

October 24, 2017

Sonoran Biosciences has filed a new provisional patent application on improved formulation and stability of SB Gel platform

Read more

August 09, 2016

Sonoran Biosciences has received a Phase 2 SBIR award from the National Institutes of Health for $1.48 million

Read more

  • © 2024 Sonoran Biosciences, Inc.
  • P: 480-389-6413
  • E: info@sonoranbiosciences.com

Website designed and developed by RainCastle Communications, Inc.

Scroll to top